Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (CA018029, CA015704, CA078902)
  • National Cancer Institute

This publication has 28 references indexed in Scilit: